Suppr超能文献

VGLUT2 是鱼藤酮诱导的多巴胺能神经元变性模型中多巴胺神经元存活能力的决定因素。

VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration.

机构信息

Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213.

Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213.

出版信息

J Neurosci. 2021 Jun 2;41(22):4937-4947. doi: 10.1523/JNEUROSCI.2770-20.2021. Epub 2021 Apr 23.

Abstract

Parkinson's disease (PD) is characterized by progressive dopamine (DA) neuron loss in the SNc. In contrast, DA neurons in the VTA are relatively protected from neurodegeneration, but the underlying mechanisms for this resilience remain poorly understood. Recent work suggests that expression of the vesicular glutamate transporter 2 (VGLUT2) selectively impacts midbrain DA neuron vulnerability. We investigated whether altered DA neuron VGLUT2 expression determines neuronal resilience in rats exposed to rotenone, a mitochondrial complex I inhibitor and toxicant model of PD. We discovered that VTA/SNc DA neurons that expressed VGLUT2 are more resilient to rotenone-induced DA neurodegeneration. Surprisingly, the density of neurons with detectable VGLUT2 expression in the VTA and SNc increases in response to rotenone. Furthermore, dopaminergic terminals within the NAc, where the majority of VGLUT2-expressing DA neurons project, exhibit greater resilience compared with DA terminals in the caudate/putamen. More broadly, VGLUT2-expressing terminals are protected throughout the striatum from rotenone-induced degeneration. Together, our data demonstrate that a distinct subpopulation of VGLUT2-expressing DA neurons are relatively protected from rotenone neurotoxicity. Rotenone-induced upregulation of the glutamatergic machinery in VTA and SNc neurons and their projections may be part of a broader neuroprotective mechanism. These findings offer a putative new target for neuronal resilience that can be manipulated to prevent toxicant-induced DA neurodegeneration in PD. Environmental exposures to pesticides contribute significantly to pathologic processes that culminate in Parkinson's disease (PD). The pesticide rotenone has been used to generate a PD model that replicates key features of the illness, including dopamine neurodegeneration. To date, longstanding questions remain: are there dopamine neuron subpopulations resilient to rotenone; and if so, what are the molecular determinants of this resilience? Here we show that the subpopulation of midbrain dopaminergic neurons that express the vesicular glutamate transporter 2 (VGLUT2) are more resilient to rotenone-induced neurodegeneration. Rotenone also upregulates VGLUT2 more broadly in the midbrain, suggesting that VGLUT2 expression generally confers increased resilience to rotenone. VGLUT2 may therefore be a new target for boosting neuronal resilience to prevent toxicant-induced DA neurodegeneration in PD.

摘要

帕金森病(PD)的特征是 SNc 中的多巴胺(DA)神经元进行性丧失。相比之下,VTA 中的 DA 神经元相对免受神经退行性变的影响,但这种弹性的潜在机制仍知之甚少。最近的研究表明,囊泡谷氨酸转运体 2(VGLUT2)的表达选择性地影响中脑 DA 神经元的脆弱性。我们研究了在暴露于鱼藤酮的大鼠中,改变 DA 神经元 VGLUT2 的表达是否决定了神经元的弹性,鱼藤酮是一种线粒体复合物 I 抑制剂和 PD 的毒性模型。我们发现,表达 VGLUT2 的 VTA/SNc DA 神经元对鱼藤酮诱导的 DA 神经退行性变更具弹性。令人惊讶的是,VTA 和 SNc 中检测到 VGLUT2 表达的神经元密度增加对鱼藤酮的反应。此外,在 NAc 中,大多数表达 VGLUT2 的 DA 神经元投射的多巴胺能末梢与尾壳核/苍白球中的 DA 末梢相比,具有更大的弹性。更广泛地说,鱼藤酮诱导的 VGLUT2 表达末梢从神经退行性变中得到了整个纹状体的保护。总之,我们的数据表明,表达 VGLUT2 的 DA 神经元的一个独特亚群相对免受鱼藤酮的神经毒性。VTA 和 SNc 神经元及其投射中谷氨酸能机制的鱼藤酮诱导上调可能是更广泛的神经保护机制的一部分。这些发现为神经元弹性提供了一个新的潜在靶点,可以通过该靶点来防止 PD 中毒性诱导的 DA 神经退行性变。环境暴露于杀虫剂会显著促进导致帕金森病(PD)的病理过程。鱼藤酮已被用于生成 PD 模型,该模型复制了该疾病的关键特征,包括多巴胺神经退行性变。迄今为止,长期存在的问题仍然存在:是否存在对鱼藤酮有弹性的多巴胺神经元亚群;如果是这样,这种弹性的分子决定因素是什么?在这里,我们表明,表达囊泡谷氨酸转运体 2(VGLUT2)的中脑多巴胺能神经元亚群对鱼藤酮诱导的神经退行性变更具弹性。鱼藤酮还更广泛地上调了 midbrain 中的 VGLUT2,这表明 VGLUT2 的表达通常赋予了对鱼藤酮的更大弹性。因此,VGLUT2 可能是一个新的靶点,可以增强神经元的弹性,以防止 PD 中毒性诱导的 DA 神经退行性变。

相似文献

1
VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration.
J Neurosci. 2021 Jun 2;41(22):4937-4947. doi: 10.1523/JNEUROSCI.2770-20.2021. Epub 2021 Apr 23.
2
Roles of VGLUT2 and Dopamine/Glutamate Co-Transmission in Selective Vulnerability to Dopamine Neurodegeneration.
ACS Chem Neurosci. 2022 Jan 19;13(2):187-193. doi: 10.1021/acschemneuro.1c00741. Epub 2022 Jan 7.
3
Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.
J Clin Invest. 2018 Feb 1;128(2):774-788. doi: 10.1172/JCI95795. Epub 2018 Jan 16.
4
Dopamine neurons exhibit emergent glutamatergic identity in Parkinson's disease.
Brain. 2022 Apr 29;145(3):879-886. doi: 10.1093/brain/awab373.
5
Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
Neuroscience. 2008 Sep 22;156(1):59-70. doi: 10.1016/j.neuroscience.2008.07.032. Epub 2008 Jul 25.
6
Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice.
Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):E11532-E11541. doi: 10.1073/pnas.1800886115. Epub 2018 Nov 15.
7
Glutamate neurons within the midbrain dopamine regions.
Neuroscience. 2014 Dec 12;282:60-8. doi: 10.1016/j.neuroscience.2014.05.032. Epub 2014 May 27.
9
Deletion of VGLUT2 in midbrain dopamine neurons attenuates dopamine and glutamate responses to methamphetamine in mice.
Pharmacol Biochem Behav. 2021 Mar;202:173104. doi: 10.1016/j.pbb.2021.173104. Epub 2021 Jan 12.

引用本文的文献

2
Parallel Gene Expression Changes in Ventral Midbrain Dopamine and GABA Neurons during Normal Aging.
eNeuro. 2025 May 29;12(5). doi: 10.1523/ENEURO.0107-25.2025. Print 2025 May.
6
Human brain proteome-wide association study provides insights into the genetic components of protein abundance in obesity.
Int J Obes (Lond). 2024 Nov;48(11):1603-1612. doi: 10.1038/s41366-024-01592-6. Epub 2024 Jul 18.
7
Aging, Parkinson's Disease, and Models: What Are the Challenges?
Aging Biol. 2023;1. doi: 10.59368/agingbio.20230010. Epub 2023 Jul 28.
8
Neurotoxicology of dopamine: Victim or assailant?
Neurotoxicology. 2024 Jul;103:175-188. doi: 10.1016/j.neuro.2024.06.001. Epub 2024 Jun 8.
9
Aging disrupts the coordination between mRNA and protein expression in mouse and human midbrain.
bioRxiv. 2024 Jun 1:2024.06.01.596950. doi: 10.1101/2024.06.01.596950.

本文引用的文献

1
VGluT2 Expression in Dopamine Neurons Contributes to Postlesional Striatal Reinnervation.
J Neurosci. 2020 Oct 21;40(43):8262-8275. doi: 10.1523/JNEUROSCI.0823-20.2020. Epub 2020 Sep 14.
2
Rotenone: from modelling to implication in Parkinson's disease.
Folia Neuropathol. 2019;57(4):317-326. doi: 10.5114/fn.2019.89857.
4
LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease.
Neurobiol Dis. 2020 Feb;134:104626. doi: 10.1016/j.nbd.2019.104626. Epub 2019 Oct 13.
5
Gene-environment interaction and Mendelian randomisation.
Rev Neurol (Paris). 2019 Dec;175(10):597-603. doi: 10.1016/j.neurol.2019.04.010. Epub 2019 Sep 19.
7
Differential Expression of VGLUT2 in Mouse Mesopontine Cholinergic Neurons.
eNeuro. 2019 Aug 20;6(4). doi: 10.1523/ENEURO.0161-19.2019. Print 2019 Jul/Aug.
8
Dopamine-glutamate neuron projections to the nucleus accumbens medial shell and behavioral switching.
Neurochem Int. 2019 Oct;129:104482. doi: 10.1016/j.neuint.2019.104482. Epub 2019 Jun 3.
9
Synaptic Vesicle Recycling Pathway Determines Neurotransmitter Content and Release Properties.
Neuron. 2019 May 22;102(4):786-800.e5. doi: 10.1016/j.neuron.2019.03.031. Epub 2019 Apr 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验